| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.0028 | 1 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.0031 | 1 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |